OpenAI released GPT-Rosalind, a reasoning model specifically tuned for life sciences research. The tool accelerates the transition from hypothesis to experiment. Access remains tightly controlled for a limited group of users. This niche optimization allows practitioners to automate complex biological reasoning tasks without the noise of general-purpose models.